Literature DB >> 10401876

Effect of smoking cessation and tobacco type on the risk of cancers of the upper aero-digestive tract in Brazil.

N F Schlecht1, E L Franco, J Pintos, L P Kowalski.   

Abstract

Tobacco smoking has long been identified as the most important risk factor for upper aero-digestive tract cancers. To investigate the effect of different tobacco types and the benefit of smoking cessation, we analyzed data from a case-control study of 784 cases of mouth, pharynx, and larynx cancers and 1,578 non-cancer controls in three metropolitan hospital areas in Brazil. Subjects were interviewed as to their smoking and drinking habits, demographics, environmental exposures, occupational history, health characteristics, and diet. Controlling for total tobacco and alcohol consumption, risks for ex-smokers compared with current smokers decreased substantially with time since cessation of the habit. Compared with never smokers, ex-smokers of >20 years had a relative risk (RR) of 1.98 [95% confidence interval (CI) = 1.0-3.8] for all upper aerodigestive tract cancers. RRs for long-term (>20 years) ex-smokers tended to be lower for mouth (RR = 1.61) and pharynx (RR = 1.52) than for larynx (RR = 3.63) cancers. The benefit of quitting was strongest for commercial cigarettes (RR = 1.45, 95% CI = 0.7-3.0) for ex-smokers of >10 years, as compared with smoking of black tobacco (RR = 2.57, 95% CI = 1.4-4.6), cigars (RR = 2.59, 95% CI = 0.6-11.6), and pipe tobacco (RR = 3.40, 95% CI = 1.3-8.8).

Entities:  

Mesh:

Year:  1999        PMID: 10401876     DOI: 10.1097/00001648-199907000-00009

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  19 in total

1.  Squamous Cell Carcinoma - Similarities and Differences among Anatomical Sites.

Authors:  Wusheng Yan; Ignacio I Wistuba; Michael R Emmert-Buck; Heidi S Erickson
Journal:  Am J Cancer Res       Date:  2011-01-01       Impact factor: 6.166

2.  Elevated levels of 1-hydroxypyrene and N'-nitrosonornicotine in smokers with head and neck cancer: A matched control study.

Authors:  Samir S Khariwala; Steven G Carmella; Irina Stepanov; Patricia Fernandes; Amy Anne Lassig; Bevan Yueh; Dorothy Hatsukami; Stephen S Hecht
Journal:  Head Neck       Date:  2012-07-17       Impact factor: 3.147

Review 3.  Basic consideration of research strategies for head and neck cancer.

Authors:  Jin Gao; Ben Panizza; Newell W Johnson; Scott Coman; Alan R Clough
Journal:  Front Med       Date:  2012-09-28       Impact factor: 4.592

Review 4.  Tobacco carcinogen metabolites and DNA adducts as biomarkers in head and neck cancer: potential screening tools and prognostic indicators.

Authors:  Samir S Khariwala; Dorothy Hatsukami; Stephen S Hecht
Journal:  Head Neck       Date:  2011-05-25       Impact factor: 3.147

Review 5.  The role of human papillomavirus in squamous carcinoma of the head and neck.

Authors:  Guojun Li; Erich M Sturgis
Journal:  Curr Oncol Rep       Date:  2006-03       Impact factor: 5.075

6.  Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma.

Authors:  Elizabeth J Franzmann; Erika P Reategui; Lutecia H Mateus Pereira; Felipe Pedroso; Debbie Joseph; Glenn O Allen; Kara Hamilton; Isildinha Reis; Robert Duncan; W Jarrard Goodwin; Jennifer J Hu; Vinata B Lokeshwar
Journal:  Head Neck       Date:  2011-07-11       Impact factor: 3.147

Review 7.  miRNAs in head and neck cancer revisited.

Authors:  Rahul Nagadia; Pratibala Pandit; William B Coman; Justin Cooper-White; Chamindie Punyadeera
Journal:  Cell Oncol (Dordr)       Date:  2013-01-22       Impact factor: 6.730

Review 8.  Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment.

Authors:  Sara I Pai; William H Westra
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

9.  Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk.

Authors:  Manuela Marron; Paolo Boffetta; Zuo-Feng Zhang; David Zaridze; Victor Wünsch-Filho; Deborah M Winn; Qingyi Wei; Renato Talamini; Neonila Szeszenia-Dabrowska; Erich M Sturgis; Elaine Smith; Stephen M Schwartz; Peter Rudnai; Mark P Purdue; Andrew F Olshan; Jose Eluf-Neto; Joshua Muscat; Hal Morgenstern; Ana Menezes; Michael McClean; Elena Matos; Ioan Nicolae Mates; Jolanta Lissowska; Fabio Levi; Philip Lazarus; Carlo La Vecchia; Sergio Koifman; Karl Kelsey; Rolando Herrero; Richard B Hayes; Silvia Franceschi; Leticia Fernandez; Eleonora Fabianova; Alexander W Daudt; Luigino Dal Maso; Maria Paula Curado; Gabriella Cadoni; Chu Chen; Xavier Castellsague; Stefania Boccia; Simone Benhamou; Gilles Ferro; Julien Berthiller; Paul Brennan; Henrik Møller; Mia Hashibe
Journal:  Int J Epidemiol       Date:  2009-10-05       Impact factor: 7.196

Review 10.  An update: emerging drugs to treat squamous cell carcinomas of the head and neck.

Authors:  Yoon Se Lee; Daniel E Johnson; Jennifer R Grandis
Journal:  Expert Opin Emerg Drugs       Date:  2018-11-16       Impact factor: 4.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.